News
Vaxxas has landed $90 million in debt and equity funding to develop technology that could replace the flu jab and other ...
CNBC-TV18’s Startup Street features Arintra, Eyestem, and DTDC Express, highlighting $21M Series A funding for AI medical ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Helio Genomics has announced a new chief executive to scale the company after beginning commercialization this year. The ...
A CEO of biotechnology company is suing Uber and his hired driver, an illegal immigrant, after the driver reportedly knocked ...
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
Vaxxas’ HD-MAP technology represents a major advance in vaccine delivery, enabling needle-free administration that reduces temperature control requirements for vaccine storage and creates ...
20h
Korea JoongAng Daily on MSNSK's Chey Tae-won meets Bill Gates to discuss nuclear energy, biotechnology cooperation
SK Group Chairman Chey Tae-won met with Bill Gates in Seoul last week to expand cooperation in nuclear energy and ...
Omnicell (OMCL) announced on Monday the appointment of Baird Radford as Executive Vice President and Chief Financial Officer, effective August 26, 2025.
Top roles at Intuitive, Boston Scientific, Dexcom and others changed hands this year. Read MedTech Dive’s roundup for all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results